Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 36
Federal Judge Says Plaintiffs' Objection to Severance Warrants Remand
Judge Finds Sales Reps Properly Joined, Remands Multi-Plaintiff Case
Calif. Vioxx Plaintiff Dismisses Claims on Eve of Trial
MDL Judge Denies Motion to Reconsider Statute of Limitations Ruling
Arthritis Drugs - Issue: 35
Merck: Plaintiffs' Unique Factual Issues Preclude Statewide Injury Classes
Plaintiffs Want Employee Depositions Postponed Pending Privilege Rulings
Plaintiffs Argue Law Doesn't Insulate Distributor Defendants from Liability
Research Watch, Arthritis Drugs, April 2007
